Clin Exp Rheumatol

1. DIZ-LOPES M, Scagliosi G, Teoni M, Pollastri F, et al
   Romosozumab effect on neutrophil-to-lymphocyte ratio in post-menopausal women at high risk of fracture.
   Clin Exp Rheumatol. 2026 Mar 4. doi: 10.55563.
   

   >> Share

   
   

   
   J Bone Miner Res

2. SCHINI M, Paggiosi MA, Gossiel F, Cummings SR, et al
   Expected change: a new concept for monitoring patients on oral bisphosphonates.
   J Bone Miner Res. 2026 Feb 23:zjag039. doi: 10.1093.
   

   >> Share

   
   

   
   J Rheumatol

3. KWON OC, Lee HS, Jeon SY, Park MC, et al
   Comparative risk of osteoporosis and osteoporotic fractures according to exposure to two groups of biologics in patients with ankylosing spondylitis.
   J Rheumatol. 2026 Mar 1:jrheum.2025-0988. doi: 10.3899/jrheum.2025-0988.
   

   >> Share

   
   

   
   Osteoporos Int

4. ALDEGHERI F, Fassio A, Appoloni M, Rotta D, et al
   Real-world rebound pattern of serum collagen type I C-telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment-induced bone loss.
   Osteoporos Int. 2026 Mar 6. doi: 10.1007/s00198-026-07936.
   

   >> Share

   
   
5. LU M, Zhou H, Li S, He L, et al
   Comment on post-fracture care and predictors of anti-osteoporotic treatment in Switzerland: a nationwide health claims analysis.
   Osteoporos Int. 2026 Mar 4. doi: 10.1007/s00198-026-07926.
   

   >> Share

   
   
6. YE C, Hans D, Schousboe JT, Binkley N, et al
   Association between trabecular bone score and cardiovascular outcomes: a population-level historical cohort study.
   Osteoporos Int. 2026;37:425-433.
   

   >> Share

   
   
7. SCHINI M, Johansson H, Harvey NC, Lorentzon M, et al
   A meta-analysis of smoking and fracture risk to update the FRAX(R) tool.
   Osteoporos Int. 2026 Mar 4. doi: 10.1007/s00198-026-07853.
   

   >> Share

   
   
8. LO JC, Chandra M, Lee C
   Response to "Comment on: The association of bone density and hip fracture risk among Asian women".
   Osteoporos Int. 2026 Mar 4. doi: 10.1007/s00198-025-07829.
   

   >> Share

   
   
9. LO JC, Chandra M, Lee C
   Response to "T-score, stature and fracture risk interpretation in Asian women".
   Osteoporos Int. 2026 Mar 4. doi: 10.1007/s00198-025-07830.
   

   >> Share

   
   
10. JANG MU, Kim MS, Hwang J, Kim HS, et al
    Bisphosphonate use is associated with reduced fracture rates in a cohort of patients with Parkinson's disease.
    Osteoporos Int. 2026 Feb 23. doi: 10.1007/s00198-026-07906.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share